Ryder System Inc. logo

Ryder System Inc.

R | NYSE
Chart Builder DCF Calculator
$282.55
+$1.87 (+0.67%)
At close: Oct 30, 2026, 4:00 PM ET
$282.55
$0.00 (0.00%)
After-hours: Oct 30, 2026, 6:00 PM ET
+0.67%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026
49.2
+9.8 pts
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #396/885 (Top 45%)

Key Statistics

Market Data

Market Cap $10.8B
1D Range
278.24 283.54
52W Range
162.50 283.54

Valuation (TTM)

PE 21.50
PB 3.63
EV/EBITDA 4.94

Valuation (NTM)

Forward PE 14.19
Forward PEG 1.30
Price Target $300.43
Loading financial charts...

Profile

Ryder System, Inc. functions as a worldwide provider of logistics and transportation services, operating through three distinct segments: Fleet Management Solutions (FMS), Supply Chain Solutions (SCS)...

Employees 51,600
IPO Date Jan 2, 1980
Fiscal Year January - December

Latest News

Does Ryder Stock's Q3 Earnings Beat Justify a Buy Decision Today?

2 days ago · zacks.com

Does Ryder Stock's Q3 Earnings Beat Justify a Buy Decision Today?
Ryder System: Too Good To Sell, Too Rich To Chase

4 days ago · seekingalpha.com

Ryder System: Too Good To Sell, Too Rich To Chase
Here's Why Ryder (R) is a Strong Growth Stock

5 days ago · zacks.com

Here's Why Ryder (R) is a Strong Growth Stock
Here's Why Ryder (R) is a Strong Momentum Stock

6 days ago · zacks.com

Here's Why Ryder (R) is a Strong Momentum Stock
Ryder System Shares Rise 2% Since Third-Quarter 2026 Earnings Release

7 days ago · zacks.com

Ryder System Shares Rise 2% Since Third-Quarter 2026 Earnings Release
Should Value Investors Buy Ryder System (R) Stock?

7 days ago · zacks.com

Should Value Investors Buy Ryder System (R) Stock?
Ryder: 3 Key Takeaways for Long-Term Investors

9 days ago · fool.com

Ryder: 3 Key Takeaways for Long-Term Investors
NEC Presents Phase I/II Results for Individualized Oral Neoantigen Therapy, NECVAX-NEO1 at ESMO 2026

10 days ago · gurufocus.com

NEC Presents Phase I/II Results for Individualized Oral Neoantigen Therapy, NECVAX-NEO1 at ESMO 2026
CO2NNEX(R) Digital Platform for Integrated Management of the Environmental Value of Sustainable Liquid Fuel (HVO) to Commence Operation in Demonstration of Sustainable Fuels Certificates Scheme

10 days ago · gurufocus.com

CO2NNEX(R) Digital Platform for Integrated Management of the Environmental Value of Sustainable Liquid Fuel (HVO) to Commence Operation in Demonstration of Sustainable Fuels Certificates Scheme
These Analysts Boost Their Forecasts On Ryder After Upbeat Q3 Results

10 days ago · benzinga.com

These Analysts Boost Their Forecasts On Ryder After Upbeat Q3 Results

Earnings

Latest Earnings
Oct 22, 2026
EPS
$4.33
Beat +4.34%
REV
$2.76B
Miss -18.39%
Next Earnings
Feb 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
9
Consensus
Buy
Price Target
$305.00
Upside
+7.95%
Buy (7)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.